The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 22, 2010

Filed:

Oct. 12, 2007
Applicants:

Esohe Ekinaduese Idusogie, Burlingame, CA (US);

Leonard G. Presta, San Francisco, CA (US);

Michael George Mulkerrin, Hillsborough, CA (US);

Inventors:

Esohe Ekinaduese Idusogie, Burlingame, CA (US);

Leonard G. Presta, San Francisco, CA (US);

Michael George Mulkerrin, Hillsborough, CA (US);

Assignee:

Genentech, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12P 21/04 (2006.01); C12P 21/06 (2006.01); C12N 5/06 (2006.01); C12N 15/00 (2006.01); C12N 15/02 (2006.01); C07K 16/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

A variant of a polypeptide comprising a human IgG Fc region is described, which variant comprises an amino acid substitution at one or more of amino acid positions 270, 322, 326, 327, 329, 331, 333 or 334 of the human IgG Fc region. Such variants display altered effector function. For example, C1q binding and/or complement dependent cytotoxicity (CDC) activity may be altered in the variant polypeptide. The application also discloses a variant of a parent polypeptide comprising a human IgG Fc region, which variant has a better binding affinity for human C1q than the parent polypeptide.


Find Patent Forward Citations

Loading…